ReNerve secures medical marketing approval in Indonesia
ReNerve (ASX:RNV) obtained marketing approval for its NervAlign Nerve Cuff in Indonesia
ReNerve (ASX:RNV) obtained marketing approval for its NervAlign Nerve Cuff in Indonesia
IFM Investors has secured a stake of well above 60% in Atlas Arteria (ASX:ALX) following a $5.10 per share.
The UK Financial Conduct Authority (FCA) has reduced the proposed capital requirement for stablecoin issuers from 2% to 1% as part of its final cryptoasset regulatory framework, with the new regime scheduled to begin in October 2027.
Compumedics (ASX:CMP) delivered record annual revenue of approximately $60.3 million following a surge in platform sales.
Solana (CRYPTO:SOL) generated its first three-day SuperTrend buy signal since October 2025, signalling a potential shift in market structure after months of sustained downward pressure.
Cardano (CRYPTO:ADA) climbed approximately 30% over the past seven days, overtaking Stellar (CRYPTO:XLM) in cryptocurrency market rankings after recovering from a period of weaker price performance.
Deribit and Signalplus have opened registration for a trading competition running from 6 July to 10 August 2026, offering a prize pool that starts at 400,000 USDC and can increase to 600,000 USDC if participants generate US$25 billion in qualifying trading volume.
Spenda (ASX:SPX) raised approximately $1.1 million through the retail component of its accelerated entitlement offer.
Strategy Executive Chairman Michael Saylor said Bitcoin (CRYPTO:BTC) is entering a new phase of adoption in which its primary role will shift from a buy-and-hold asset to digital capital supporting lending.
The Canary HBAR ETF recorded US$989,000 in net inflows on 2 July, its largest single-day inflow since 15 May, while continuing to provide regulated exposure to Hedera (CRYPTO:HBAR) through traditional brokerage accounts.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas